Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and Cardiovascular Issues in Pregnancy.
Analysis of Pulsatile Vessel Expansion in Healthy, <scp>COPD</scp> ‐ and <scp>PH</scp> ‐Patients Using Dynamic Vessel Segmentation in Free‐Breathing Lung <scp>MRI</scp>
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies
Severe Hypoxemia and Pulmonary Capillary Dilatations in Pulmonary Arterial Hypertension Patients Treated with Sotatercept
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
Withdrawal of prostacyclin pathway therapies after initiation of sotatercept treatment in patients with pulmonary arterial hypertension
Mono and Combination Therapies in Pulmonary Arterial Hypertension Patients with Comorbidities: A COMPERA Analysis
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat <i>versus</i> other medications: a COMPERA analysis
Add-on therapy with parenteral prostacyclin analogues in patients with pulmonary arterial hypertension: Insights from the COMPERA registry
Management of pulmonary hypertension in special conditions
Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
Effect of sotatercept on circulating proteomics in pulmonary arterial hypertension
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
Loss of pulmonary capillaries in idiopathic pulmonary arterial hypertension with low diffusion capacity is accompanied by early diffuse emphysema detected by 129Xe MRI
Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis
Multicenter Standardization of Phase‐Resolved Functional Lung <scp>MRI</scp> in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
A Morphomolecular Approach to Alveolar Capillary Dysplasia
Sotatercept for the Treatment of Pulmonary Arterial Hypertension